Weight Loss with GLP-1s in Everyday Care: Vanderbilt Study Shows Gaps vs. Clinical Trials
Michael Albert, Co-Founder, Chief Medical Officer at Accomplish Health posted on X:
”Real-World GLP-1 Data: Vanderbilt Obesity Clinic Study (n=2,306)
Clinical trials showed 15–21% weight loss with semaglutide and tirzepatide. But how do patients actually fare in practice?
Key Findings:
Median treatment duration: 10.7 months (50% discontinued by 12 months)
Only 23% reached semaglutide 2.4 mg, 28% reached tirzepatide 15 mg
Weight loss for those who continued treatment:
• 6 months: –9.4%
• 12 months: –14.4%
13.6% had medication-related ER visits (mostly GI side effects)
Context:
This was not a typical setting—patients had multidisciplinary support and NO-COST medication access through employer insurance bundles.
Reality Check:
– With the right care model, real-world outcomes can approach RCTs
– Most patients never reach target doses
– Half stop treatment within a year
The gap between “can work” and “does work” remains large. Sustained success appears tied to comprehensive care models that most patients can’t easily access.”
Read the full study here.
Stay updated with Hemostasis Today.
-
Apr 16, 2026, 05:22Cedric Hermans: A Simple Way to Stay Updated in Haemophilia and von Willebrand Disease
-
Apr 16, 2026, 04:29Vijay Shah: Increasing Value of AI-Based Assessment in Cardiovascular Risk Prediction
-
Apr 16, 2026, 04:13Mysa Saad: Antiplatelets Increase Bleeding Without Reducing VTE in Cancer Patients
-
Apr 16, 2026, 04:11Paolo Zamboni: Enjoy the New Super Articles From Veins and Lymphatics Page Press
-
Apr 16, 2026, 04:03Platelet DGD – A Common But Underdiagnosed Bleeding Disorder – RPTH
-
Apr 16, 2026, 03:51William Wallace: How Vitamin B12 Is Being Absorbed?
-
Apr 16, 2026, 03:36Santagata Davide: Atypical Vascular Events Revealing Underlying Clonal Autoinflammation
-
Apr 16, 2026, 03:35Iron Deficiency in Women During Reproductive Years – ASH
-
Apr 16, 2026, 03:33Abdallah Othman: Overview of Coronary Arterial Anatomy and Its Clinical Implications